BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 33368857)

  • 1. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
    Shigeta K; Matsumoto K; Tanaka N; Mikami S; Kosaka T; Yasumizu Y; Takeda T; Mizuno R; Kikuchi E; Oya M
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
    Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
    J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
    Sung HH; Jeon HG; Han DH; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    PLoS One; 2015; 10(11):e0139976. PubMed ID: 26556239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
    Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q
    Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
    Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
    Xylinas E; Colin P; Audenet F; Phe V; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Polguer T; Ruffion A; Valeri A; Rozet F; Long JA; Zerbib M; Rouprêt M
    World J Urol; 2013 Feb; 31(1):61-8. PubMed ID: 23053211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
    Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
    Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
    Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
    Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
    J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.